Coronavirus disease (COVID-19) latest news and information

Evaxion and ExpreS2ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate

content — Tue, 13 Dec 2022 15:58:31 +0000

Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announces that the Company has signed a Vaccine Discovery Collaboration Agreement with ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) for the joint development of a novel cytomegalovirus (CMV) vaccine candidate. During the discovery phase of the collaboration, Evaxion […]

The post Evaxion and ExpreS2ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate first appeared on World Pharma Today.

Pfizer and BioNTech Receive U.S. FDA EUA for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

content — Tue, 13 Dec 2022 15:56:04 +0000

Pfizer Inc. and BioNTech SE announced the U.S. FDA granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age. Children in this age group can receive a primary series consisting of two 3-µg doses […]

The post Pfizer and BioNTech Receive U.S. FDA EUA for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years first appeared on World Pharma Today.

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17

content — Mon, 15 Aug 2022 11:48:51 +0000

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner, SK bioscience, has received a Post Approval Change Application approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by […]

The post Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17 first appeared on World Pharma Today.

200M COVID Jab Left Over Doses Leads SII Halting Production

content — Mon, 25 Apr 2022 16:04:30 +0000

As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world’s largest vaccine manufacturer’s warehouses. As per Bloomberg, Serum Institute of India (SII) CEO Adar Poonawalla revealed at the India Economic Conclave that they had ceased producing fresh COVID-19 vaccine doses in December. According to him, the company now has a […]

The post 200M COVID Jab Left Over Doses Leads SII Halting Production first appeared on World Pharma Today.

Sanofi Starts Work On €400 Million Smart Space In Singapore

content — Mon, 25 Apr 2022 16:01:12 +0000

Sanofi’s “factory of the future” in Singapore could be operational by the middle of the decade. One of two so-called Evolutive Vaccine Facilities (EVFs) that the French drugmaker is building with a collective investment of 900 million euros (about $976 million) has begun construction. In France, the other factory is starting up. According to the […]

The post Sanofi Starts Work On €400 Million Smart Space In Singapore first appeared on World Pharma Today.

Kings College Uses COVID-19 Tech To Treat Heart Attacks

content — Fri, 22 Apr 2022 12:51:27 +0000

King’s College London, a public research university, is using messenger RNA (mRNA) technology to battle the physiological effects of cardiac arrest in the hopes of developing the world’s first heart attack treatment. The technology has the ability to reverse cardiac damage to a large extent. Such has been the devastating effect of COVID-19 that the […]

The post Kings College Uses COVID-19 Tech To Treat Heart Attacks first appeared on World Pharma Today.

Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan

content — Tue, 19 Apr 2022 13:25:15 +0000

Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection (Nuvaxovid), a novel recombinant protein-based COVID-19 vaccine, for primary and booster immunization in individuals aged 18 and older. Novavax licensed and transferred its manufacturing technologies to enable Takeda to develop and […]

The post Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan first appeared on World Pharma Today.

More COVID Cases In Shanghai Lead To Stiffer City-Wide Bans

content — Mon, 18 Apr 2022 13:27:03 +0000

On April 16th, Shanghai reported a new high for symptomatic COVID-19 cases, while other cities throughout China tightened controls as the country continued its “dynamic clearing” strategy to eradicate the highly communicable Omicron form. A day before, the Zhengzhou Airport Economic Zone, one of the central Chinese manufacturing areas where Apple Inc. supplier Foxconn is located, […]

The post More COVID Cases In Shanghai Lead To Stiffer City-Wide Bans first appeared on World Pharma Today.

Is It Really Possible To Attain COVID-19 Herd Immunity?

content — Mon, 18 Apr 2022 13:23:45 +0000

The fresh, new, astonishingly efficient COVID-19 vaccines were rolling out across the US this time last year, injecting a strong note of confidence into the country’s formerly stumbling pandemic response. Hundreds of thousands of people were queuing up every day to get their vaccinations. Researchers were monitoring a new number: the proportion of Americans who had been […]

The post Is It Really Possible To Attain COVID-19 Herd Immunity? first appeared on World Pharma Today.

Covaxin Trials In The United States Have Been Put On Hold

content — Mon, 18 Apr 2022 11:11:48 +0000

The phase 2/3 clinical trials for Bharat Biotech’s COVID-19 vaccine, Covaxin, in the United States have been halted by the US Food and Drug Administration. As per a press release from Ocugen Inc., Bharat Biotech’s partner for Covaxin in the United States and Canada, the FDA’s decision was based on the US firm’s decision to […]

The post Covaxin Trials In The United States Have Been Put On Hold first appeared on World Pharma Today.